Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (FY)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2.11M | 0 | 0 | 0 | 0 | 0 | -18.47%65.97M | 62.64M | 0 | -12.02%80.91M |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -5.69%1.05B | -39.73%1.12B | -14.78%286.59M | -57.63%247.81M | 243.58M | 338.22M | 1.26%1.85B | 336.27M | 584.88M | 37.35%1.83B |
| Selling and administrative expenses | 9.42%385.01M | -2.47%351.87M | 1.55%84.31M | -23.60%85.03M | --85.29M | --97.23M | 4.00%360.77M | --83.03M | --111.3M | -7.25%346.89M |
| -Selling and marketing expense | 9.42%385.01M | -2.47%351.87M | 1.55%84.31M | -23.60%85.03M | --85.29M | --97.23M | 4.00%360.77M | --83.03M | --111.3M | -7.25%346.89M |
| Research and development costs | -12.64%667.69M | -48.75%764.33M | -20.13%202.27M | -65.63%162.78M | --158.29M | --240.99M | 0.61%1.49B | --253.24M | --473.58M | 54.77%1.48B |
| Operating profit | 5.88%-1.05B | 37.50%-1.12B | -4.73%-286.59M | 57.63%-247.81M | -243.58M | -338.22M | -2.17%-1.79B | -273.63M | -584.88M | -41.02%-1.75B |
| Net non-operating interest income (expenses) | 36.00%-2.13M | 62.77%-3.32M | -1,164.74%-3.32M | 0 | -257.31%-8.92M | 312K | 87.62%-2.5M | |||
| Non-operating interest income | 380.61%1.74M | -73.97%361K | ---- | ---- | ---- | ---- | 1,095.69%1.39M | ---- | ---- | -53.23%116K |
| Total other finance cost | 4.83%3.86M | -64.27%3.68M | ---- | ---- | ---- | ---- | 294.53%10.31M | --1.08M | ---- | -87.20%2.61M |
| Net investment income | -106.48%-660K | -51.52%10.18M | 1,441.21%8.94M | 96.17%-151K | -145K | 1.54M | 87.60%21M | 580K | -3.94M | 222.49%11.19M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 160.21%3.03M | 20.70%1.17M | -14.88%286K | 73.94%327K | 301K | 252K | -38.43%966K | 336K | 188K | 1.57M |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 92.87%-2.87M | -1,516.49%-40.2M | -1,172.22%-40.2M | 0 | 94.82%-2.49M | -3.16M | 0 | -4,774.21%-48.01M | ||
| Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---673K | --0 | --0 | ---- |
| Less:Write off | -92.87%2.87M | 1,172.22%40.2M | ---- | ---- | ---- | ---- | -93.42%3.16M | ---- | ---- | --48.01M |
| Other non-operating income (expenses) | -71.69%35.48M | 1.33%125.35M | 0.17%99.72M | -76.97%35K | 23.85M | 1.75M | 20.90%123.69M | 99.54M | 152K | 21.88%102.31M |
| Income before tax | 0.52%-1.02B | 38.07%-1.02B | -25.65%-221.17M | 58.58%-247.6M | -219.57M | -334.69M | 1.89%-1.65B | -176.02M | -597.72M | -41.95%-1.68B |
| Income tax | 0.00%1.21M | 0.00%1.21M | 0.00%303K | 0.00%302K | 303K | 302K | 0.00%1.21M | 303K | 302K | 0.00%1.21M |
| Net income | 0.52%-1.02B | 38.04%-1.02B | -25.61%-221.47M | 58.55%-247.9M | -219.87M | -334.99M | 1.88%-1.65B | -176.32M | -598.02M | -41.91%-1.68B |
| Net income continuous operations | 0.52%-1.02B | 38.04%-1.02B | -25.61%-221.47M | 58.55%-247.9M | ---219.88M | ---334.99M | 1.88%-1.65B | ---176.32M | ---598.02M | -41.91%-1.68B |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 0.52%-1.02B | 38.04%-1.02B | -25.61%-221.47M | 58.55%-247.9M | -219.87M | -334.99M | 1.88%-1.65B | -176.32M | -598.02M | -41.91%-1.68B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 0.52%-1.02B | 38.04%-1.02B | -25.61%-221.47M | 58.55%-247.9M | -219.87M | -334.99M | 1.88%-1.65B | -176.32M | -598.02M | -41.91%-1.68B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 12.16%-25.21 | 45.99%-28.7 | -89.60%-6.2 | 63.61%-6.95 | -6.16 | -9.39 | 11.36%-53.14 | -3.27 | -19.1 | -29.85%-59.95 |
| Diluted earnings per share | 12.16%-25.21 | 45.99%-28.7 | -25.49%-6.2 | 66.81%-6.95 | -6.1612 | -9.39 | 11.36%-53.14 | -4.9406 | -20.9395 | -29.85%-59.95 |
| Dividend per share | ||||||||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |